Amgen will pay $50 million upfront to fund the five programs, with a potential transaction value of $1.9 billion plus future royalties, according to a Jan. 6 press release.
For each program, Amgen will pay up to $370 million in future milestones and royalties. It will also participate in a future financing round for Generate.
Cambridge, Mass.-based Generate Biomedicines is a company that uses machine learning and AI to program protein therapeutics.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
